Faith Nguyen
Nurse Practitioner · Frederick, MDNPI 1699175737
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $587, 6.3 times the $92 reported in 2021.
Across 73 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$318
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$226
- Supernus Pharmaceuticals, Inc.$220
- Otsuka America Pharmaceutical, Inc.$216
- Takeda Pharmaceuticals U.S.A., Inc.$137
- Axsome Therapeutics, Inc.$128
- plus $212 from 7 others
What the payments were for
- Food & beverage$1,41097%
- Education$473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,457 in reported general payments places this provider in the 85th percentile of 1,562 nurse practitioner providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,371 |
| Sertraline Hcl | 11 | $435 |
| Duloxetine Hcl | 17 | $304 |
| Escitalopram Oxalate | 15 | $259 |
| Trazodone Hcl | 16 | $253 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Frederick
- Janet Dakers BidleFrederick$5K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
- Stephanie ZwonitzerAnnapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.